hypericin

hypericin is a lipid of Polyketides (PK) class. Hypericin is associated with abnormalities such as Dermatitis, Phototoxic, Dehydration, Photosensitization, Morphologically altered structure and Myocardial Infarction. The involved functions are known as Cell Cycle Checkpoints, Apoptosis, Acetylation, Cell Survival and Caspase Activation. Hypericin often locates in insoluble fraction, Cytoplasmic matrix, Protoplasm, Tissue membrane and Cytoplasm. The associated genes with hypericin are CDC37 gene, HSPA8 gene, RAF1 gene, cyclin H and FK228. The related lipids are Phosphatidylserines.

Cross Reference

Introduction

To understand associated biological information of hypericin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with hypericin?

hypericin is suspected in Dermatitis, Phototoxic, Photosensitization, Pneumonia, Psoriasis, Phototoxicity, Chronic infectious disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with hypericin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uterine Cervical Neoplasms D002583 10 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Neoplasms, Radiation-Induced D009381 3 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Burns D002056 34 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Per page 10 20 50 | Total 38

PubChem Associated disorders and diseases

What pathways are associated with hypericin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with hypericin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with hypericin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with hypericin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with hypericin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with hypericin?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with hypericin

Download all related citations
Per page 10 20 50 100 | Total 1000
Authors Title Published Journal PubMed Link
Krishnamoorthy G et al. Synthesis of hydroxy and methoxy perylene quinones, their spectroscopic and computational characterization, and their antiviral activity. Photochem. Photobiol. pmid:15884972
Traynor NJ et al. Photogenotoxicity of hypericin in HaCaT keratinocytes: implications for St. John's Wort supplements and high dose UVA-1 therapy. 2005 Toxicol. Lett. pmid:15890476
Sim HG et al. Is photodynamic diagnosis using hypericin better than white-light cystoscopy for detecting superficial bladder carcinoma? 2005 BJU Int. pmid:15892804
Martínez-Poveda B et al. Hypericin in the dark inhibits key steps of angiogenesis in vitro. 2005 Eur. J. Pharmacol. pmid:15921677
Saw CL et al. Transport of hypericin across chick chorioallantoic membrane and photodynamic therapy vasculature assessment. 2005 Biol. Pharm. Bull. pmid:15930744
Du H et al. Hypericin-mediated photodynamic therapy elicits differential interleukin-6 response in nasopharyngeal cancer. 2006 Cancer Lett. pmid:15935550
Huygens A et al. Permeation of hypericin in spheroids composed of different grade transitional cell carcinoma cell lines and normal human urothelial cells. 2005 J. Urol. pmid:15947580
Kascakova S et al. Fluorescence spectroscopic study of hypericin-photosensitized oxidation of low-density lipoproteins. 2005 Nov-Dec Photochem. Photobiol. pmid:15960595
Jain S and Kockelbergh RC The role of photodynamic diagnosis in the contemporary management of superficial bladder cancer. 2005 BJU Int. pmid:15963113
Bourke CA and White JG Reassessment of the toxicity of Hypericum perforatum (St John's wort) for cattle. 2004 Aust. Vet. J. pmid:15977618
Gadzovska S et al. Identification and quantification of hypericin and pseudohypericin in different Hypericum perforatum L. in vitro cultures. 2005 Plant Physiol. Biochem. pmid:15979315
Xu Y and Lu C Raman spectroscopic study on structure of human immunodeficiency virus (HIV) and hypericin-induced photosensitive damage of HIV. 2005 Sci. China, C, Life Sci. pmid:15986884
Zhou Q et al. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models. 2005 Cancer Chemother. Pharmacol. pmid:16001166
Zaak D et al. Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy. 2005 BJU Int. pmid:16001963
Singh YN Potential for interaction of kava and St. John's wort with drugs. 2005 J Ethnopharmacol pmid:16005588
Weinberger D et al. Competitive quenching: a possible novel approach in protecting RPE cells from damage during PDT. 2005 Curr. Eye Res. pmid:16020257
Thomas C et al. Photoactivation of hypericin generates singlet oxygen in mitochondria and inhibits succinoxidase. 1992 Photochem. Photobiol. pmid:1603850
Saw CL et al. Enhanced photodynamic activity of hypericin by penetration enhancer N-methyl pyrrolidone formulations in the chick chorioallantoic membrane model. 2006 Cancer Lett. pmid:16054752
Sarissky M et al. Diazepam enhances hypericin-induced photocytotoxicity and apoptosis in human glioblastoma cells. 2005 Neoplasma pmid:16059654
Lavie G et al. Anti-angiogenic activities of hypericin in vivo: potential for ophthalmologic applications. 2005 Angiogenesis pmid:16132616
Xu MJ et al. Nitric oxide mediates the fungal elicitor-induced hypericin production of Hypericum perforatum cell suspension cultures through a jasmonic-acid-dependent signal pathway. 2005 Plant Physiol. pmid:16169960
Cavarga I et al. Photoinduced antitumour effect of hypericin can be enhanced by fractionated dosing. 2005 Phytomedicine pmid:16194057
Thong PS et al. Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT. 2006 J. Photochem. Photobiol. B, Biol. pmid:16203156
Du HY et al. Expression of Y-Box binding protein-1 following hypericin-mediated photodynamic therapy in well-differentiated nasopharyngeal cancer in vivo. 2005 Int. J. Mol. Med. pmid:16211256
Lee HB et al. p53 Status does not affect photodynamic cell killing induced by hypericin. 2006 Cancer Chemother. Pharmacol. pmid:16211395
Crnolatac I et al. Synthesis, in vitro cellular uptake and photo-induced antiproliferative effects of lipophilic hypericin acid derivatives. 2005 Bioorg. Med. Chem. pmid:16213734
Hendrickx N et al. Targeted inhibition of p38alpha MAPK suppresses tumor-associated endothelial cell migration in response to hypericin-based photodynamic therapy. 2005 Biochem. Biophys. Res. Commun. pmid:16214108
Gioti EM et al. Single-drop liquid-phase microextraction for the determination of hypericin, pseudohypericin and hyperforin in biological fluids by high performance liquid chromatography. 2005 J Chromatogr A pmid:16233865
Ritz R et al. Hypericin: a promising fluorescence marker for differentiating between glioblastoma and neurons in vitro. 2005 Int. J. Oncol. pmid:16273210
Yee KK et al. Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma. 2005 Int. J. Mol. Med. pmid:16273277
Schulz HU et al. Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers. 2005 Arzneimittelforschung pmid:16294501
Saw CL et al. Delivery of hypericin for photodynamic applications. 2006 Cancer Lett. pmid:16303248
Shah AK et al. Content analysis and stability evaluation of selected commercial preparations of St. John's wort. 2005 Drug Dev Ind Pharm pmid:16306003
Beattie PE et al. Can St John's wort (hypericin) ingestion enhance the erythemal response during high-dose ultraviolet A1 therapy? 2005 Br. J. Dermatol. pmid:16307656
Zobayed SM et al. Temperature stress can alter the photosynthetic efficiency and secondary metabolite concentrations in St. John's wort. Plant Physiol. Biochem. pmid:16310362
Smelcerovic A et al. Phytochemical analysis and genetic characterization of six Hypericum species from Serbia. 2006 Phytochemistry pmid:16324730
Shen L et al. Anion of hypericin is crucial to understanding the photosensitive features of the pigment. 2006 Bioorg. Med. Chem. Lett. pmid:16337376
Mueller SC et al. The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin dose. 2006 Eur. J. Clin. Pharmacol. pmid:16341856
Lawvere S and Mahoney MC St. John's wort. 2005 Am Fam Physician pmid:16342849
Sacková V et al. Hypericin-mediated photocytotoxic effect on HT-29 adenocarcinoma cells is reduced by light fractionation with longer dark pause between two unequal light doses. 2005 Nov-Dec Photochem. Photobiol. pmid:16354114
Chandrasekera DH et al. Quantitative analysis of the major constituents of St John's wort with HPLC-ESI-MS. 2005 J. Pharm. Pharmacol. pmid:16354409
Ito M et al. Approach to novel functional foods for stress control 4. Regulation of serotonin transporter by food factors. 2005 J. Med. Invest. pmid:16366509
Caccia S Antidepressant-like components of Hypericum perforatum extracts: an overview of their pharmacokinetics and metabolism. 2005 Curr. Drug Metab. pmid:16379667
Skalkos D et al. Photophysical properties of Hypericum perforatum L. extracts--novel photosensitizers for PDT. 2006 J. Photochem. Photobiol. B, Biol. pmid:16388961
Kocanova S et al. Characterization of the interaction of hypericin with protein kinase C in U-87 MG human glioma cells. 2006 May-Jun Photochem. Photobiol. pmid:16396605
Randløv C et al. The efficacy of St. John's Wort in patients with minor depressive symptoms or dysthymia--a double-blind placebo-controlled study. 2006 Phytomedicine pmid:16423519
Sun YX et al. [Effects of hypericin associated with light irradiation on human laryngeal squamous cell carcinoma strain Hep-2]. 2005 Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi pmid:16429734
Pal D and Mitra AK MDR- and CYP3A4-mediated drug-herbal interactions. 2006 Life Sci. pmid:16442130
Ni Y et al. First preclinical evaluation of mono-[123I]iodohypericin as a necrosis-avid tracer agent. 2006 Eur. J. Nucl. Med. Mol. Imaging pmid:16450141
Buytaert E et al. Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy. 2006 FASEB J. pmid:16455754
Urbanová M et al. Genetic and biochemical analysis of Hypericum perforatum L. plants regenerated after cryopreservation. 2006 Plant Cell Rep. pmid:16456647
Van De Putte M et al. The impact of aggregation on the biodistribution of hypericin. 2006 Int. J. Oncol. pmid:16465370
Kamuhabwa AR et al. Enhancing the photodynamic effect of hypericin in human bladder transitional cell carcinoma spheroids by the use of the oxygen carrier, perfluorodecalin. 2006 Int. J. Oncol. pmid:16465384
Sobaci G et al. Hypericin-enhanced argon laser photocoagulation for subfoveal choroidal neovascular membrane in age-related macular degeneration: a pilot study. 2006 Jan-Feb Eur J Ophthalmol pmid:16496255
Hudson JB et al. Antiviral activities of hypericin. 1991 Antiviral Res. pmid:1650164
Sun Y et al. [Effects of hypericin associated with radiotherapy on human laryngeal squamous cell carcinoma strain Hep-2]. 2005 Lin Chuang Er Bi Yan Hou Ke Za Zhi pmid:16512491
Baugh SF Simultaneous determination of protopseudohypericin, pseudohypericin, protohypericin, and hypericin without light exposure. 2005 Nov-Dec J AOAC Int pmid:16526439
Dasgupta A et al. St. John's wort does not interfere with therapeutic drug monitoring of 12 commonly monitored drugs using immunoassays. 2006 J. Clin. Lab. Anal. pmid:16538644
Kleban J et al. Pre-treatment of HT-29 cells with 5-LOX inhibitor (MK-886) induces changes in cell cycle and increases apoptosis after photodynamic therapy with hypericin. 2006 J. Photochem. Photobiol. B, Biol. pmid:16545574
Dabrowski MJ et al. Glutathione S-transferase P1-1 expression modulates sensitivity of human kidney 293 cells to photodynamic therapy with hypericin. 2006 Arch. Biochem. Biophys. pmid:16546115
Mukherjee P et al. Maristentorin, a novel pigment from the positively phototactic marine ciliate Maristentor dinoferus, is structurally related to hypericin and stentorin. 2006 J Phys Chem B pmid:16553454
Williams FB et al. Development and evaluation of methods for determination of naphthodianthrones and flavonoids in St. John's wort. 2006 J Chromatogr A pmid:16554056
Tirillini B et al. Induction of hypericins in Hypericum perforatum in response to chromium. 2006 Fitoterapia pmid:16554124
Berlanda J et al. Characterization of apoptosis induced by photodynamic treatment with hypericin in A431 human epidermoid carcinoma cells. 2006 J. Environ. Pathol. Toxicol. Oncol. pmid:16566716
Olivo M and Chin W Perylenequinones in photodynamic therapy: cellular versus vascular response. 2006 J. Environ. Pathol. Toxicol. Oncol. pmid:16566720
Smelcerovic A et al. Comparison of methods for the exhaustive extraction of hypericins, flavonoids, and hyperforin from Hypericum perforatum L. 2006 J. Agric. Food Chem. pmid:16569071
Lopez-Bazzocchi I et al. Antiviral activity of the photoactive plant pigment hypericin. 1991 Photochem. Photobiol. pmid:1658826
Smelcerovic A and Spiteller M Phytochemical analysis of nine Hypericum L. species from Serbia and the F.Y.R. Macedonia. 2006 Pharmazie pmid:16599273
Jankowski A et al. The action of photosensitizers and serum in a bactericidal process. II. The effects of dyes: hypericin, eosin Y and saphranine O. 2005 Pol. J. Microbiol. pmid:16599305
Schmitt LA et al. Evaluation of the light-sensitive cytotoxicity of Hypericum perforatum extracts, fractions, and pure compounds. 2006 J. Agric. Food Chem. pmid:16608204
Wolkenstein K et al. Preservation of hypericin and related polycyclic quinone pigments in fossil crinoids. 2006 Proc. Biol. Sci. pmid:16615212
Schulz HU et al. Investigation of the effect on photosensitivity following multiple oral dosing of two different hypericum extracts in healthy men. 2006 Arzneimittelforschung pmid:16618014
Wurglics M and Schubert-Zsilavecz M Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients. 2006 Clin Pharmacokinet pmid:16640452
Andersen DO et al. In vitro virucidal activity of selected anthraquinones and anthraquinone derivatives. 1991 Antiviral Res. pmid:1665961
Gupta V et al. Enhancement of glioblastoma cell killing by combination treatment with temozolomide and tamoxifen or hypericin. 2006 Neurosurg Focus pmid:16709026
Sacková V et al. Hypericin-induced photocytotoxicity is connected with G2/M arrest in HT-29 and S-phase arrest in U937 cells. 2006 Sep-Oct Photochem. Photobiol. pmid:16740057
Rückert U et al. A high-performance liquid chromatography with electrochemical detection for the determination of total hypericin in extracts of St. John's Wort. 2006 May-Jun Phytochem Anal pmid:16749423
Gutmann H et al. Hypericum perforatum: which constituents may induce intestinal MDR1 and CYP3A4 mRNA expression? 2006 Planta Med. pmid:16755466
Cooper EL Stem cells and CAM. 2006 Evid Based Complement Alternat Med pmid:16786045
Schipper ML et al. Evaluation of firefly luciferase bioluminescence mediated photodynamic toxicity in cancer cells. 2006 Jul-Aug Mol Imaging Biol pmid:16791748
Kasper S et al. Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298]. 2006 BMC Med pmid:16796730
Theodossiou TA et al. Mitochondria are a primary target of hypericin phototoxicity: synergy of intracellular calcium mobilisation in cell killing. 2006 Int. J. Biochem. Cell Biol. pmid:16814590
Laptev R et al. Intracellular chemiluminescence activates targeted photodynamic destruction of leukaemic cells. 2006 Br. J. Cancer pmid:16819545
Halder M et al. Interaction of glutathione S-transferase with hypericin: A photophysical study. 2005 J Phys Chem B pmid:16853517
Schmitt LA et al. Reduction in hypericin-induced phototoxicity by Hypericum perforatum extracts and pure compounds. 2006 J. Photochem. Photobiol. B, Biol. pmid:16859921
Bublik M et al. Hypericin and pulsed laser therapy of squamous cell cancer in vitro. 2006 Photomed Laser Surg pmid:16875442
Grimm T et al. Single and multiple dose pharmacokinetics of maritime pine bark extract (pycnogenol) after oral administration to healthy volunteers. 2006 BMC Clin Pharmacol pmid:16887024
Zobayed SM et al. Plant-environment interactions: Accumulation of hypericin in dark glands of Hypericum perforatum. 2006 Ann. Bot. pmid:16891333
Eto I "Nutritional and chemopreventive anti-cancer agents up-regulate expression of p27Kip1, a cyclin-dependent kinase inhibitor, in mouse JB6 epidermal and human MCF7, MDA-MB-321 and AU565 breast cancer cells". 2006 Cancer Cell Int. pmid:16899133
Spiess PE and Grossman HB Fluorescence cystoscopy: is it ready for use in routine clinical practice? 2006 Curr Opin Urol pmid:16905985
Kiesslich T et al. Cellular mechanisms and prospective applications of hypericin in photodynamic therapy. 2006 Curr. Med. Chem. pmid:16918348
Zeisser-Labouèbe M et al. Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer. 2006 Int J Pharm pmid:16930882
Putnik K et al. Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy -- case report and review of literature. 2006 Radiat Oncol pmid:16948841
Tamaoki T et al. Calphostin (UCN1028) and calphostin related compounds, a new class of specific and potent inhibitors of protein kinase C. 1990 Adv. Second Messenger Phosphoprotein Res. pmid:1698411
Portolés A et al. Effects of Hypericum perforatum on ivabradine pharmacokinetics in healthy volunteers: an open-label, pharmacokinetic interaction clinical trial. 2006 J Clin Pharmacol pmid:16988208
Kosuth J et al. Expression of the hyp-1 gene in early stages of development of Hypericum perforatum L. 2007 Plant Cell Rep. pmid:16988829
Tang J et al. Virucidal activity of hypericin against enveloped and non-enveloped DNA and RNA viruses. 1990 Antiviral Res. pmid:1699494
Kraus GA et al. Antiretroviral activity of synthetic hypericin and related analogs. 1990 Biochem. Biophys. Res. Commun. pmid:1699534
Ung CY et al. In silico prediction of pregnane X receptor activators by machine learning approaches. 2007 Mol. Pharmacol. pmid:17003167
Weber B [Sunburn -- or yet not?]. 2006 MMW Fortschr Med pmid:17036958